38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) (TARG)

The EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics is the leading international meeting on the discovery and development of new cancer drugs. It brings together academic, industry and regulatory scientists to present advances in target identification and validation, small molecules, antibodies and antibody-drug conjugates, protein degraders, cell and gene therapies, drug resistance, biomarkers and companion diagnostics, early-phase clinical trial design, and the translation of preclinical findings to patients. Abstracts are invited for poster and proffered-paper presentation alongside plenary and educational sessions, and are published in a journal supplement.